Stay updated on Avelumab First-line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab First-line NSCLC Clinical Trial page.

Latest updates to the Avelumab First-line NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe NIH site-wide notice about its transition from “Artificial Intelligence” to “Super Intelligence” is no longer shown. The site revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.4%

- Check20 days agoChange DetectedA site-wide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to related updates and FAQs.SummaryDifference0.4%

- Check27 days agoChange DetectedThe ClinicalTrials.gov footer revision advanced from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe website footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedA new site revision entry, Revision: v3.7.0, was added to the history, and Revision: v3.6.6 was removed. This updates the platform's versioning log rather than altering the study's information.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 in the record history, indicating a newer build of the site's interface. This change is a frontend update and does not alter the underlying study data or record content.SummaryDifference0.1%

Stay in the know with updates to Avelumab First-line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab First-line NSCLC Clinical Trial page.